183 related articles for article (PubMed ID: 34529346)
1. Fractionated stereotactic radiotherapy for uveal melanoma: Long-term outcome and control rates.
van Beek JGM; van Rij CM; Baart SJ; Yavuzyigitoglu S; Bergmann MJ; Paridaens D; Naus NC; Kiliç E
Acta Ophthalmol; 2022 Aug; 100(5):511-519. PubMed ID: 34529346
[TBL] [Abstract][Full Text] [Related]
2. Local tumour control and radiation side effects for fractionated stereotactic photon beam radiotherapy compared to proton beam radiotherapy in uveal melanoma.
van Beek JGM; Ramdas WD; Angi M; van Rij CM; Naus NC; Kacperek A; Errington RD; Damato B; Heimann H; Kiliç E
Radiother Oncol; 2021 Apr; 157():219-224. PubMed ID: 33549643
[TBL] [Abstract][Full Text] [Related]
3. Fractionated stereotactic radiotherapy for uveal melanoma, late clinical results.
Muller K; Naus N; Nowak PJ; Schmitz PI; de Pan C; van Santen CA; Marijnissen JP; Paridaens DA; Levendag PC; Luyten GP
Radiother Oncol; 2012 Feb; 102(2):219-24. PubMed ID: 21864922
[TBL] [Abstract][Full Text] [Related]
4. Radiation related complications after ruthenium plaque radiotherapy of uveal melanoma.
Summanen P; Immonen I; Kivelä T; Tommila P; Heikkonen J; Tarkkanen A
Br J Ophthalmol; 1996 Aug; 80(8):732-9. PubMed ID: 8949719
[TBL] [Abstract][Full Text] [Related]
5. Stereotactic Radiosurgery and Fractionated Stereotactic Radiation Therapy for the Treatment of Uveal Melanoma.
Yazici G; Kiratli H; Ozyigit G; Sari SY; Cengiz M; Tarlan B; Mocan BO; Zorlu F
Int J Radiat Oncol Biol Phys; 2017 May; 98(1):152-158. PubMed ID: 28586956
[TBL] [Abstract][Full Text] [Related]
6. Linear accelerator-based stereotactic fractionated photon radiotherapy as an eye-conserving treatment for uveal melanoma.
Akbaba S; Foerster R; Nicolay NH; Arians N; Bostel T; Debus J; Hauswald H
Radiat Oncol; 2018 Aug; 13(1):140. PubMed ID: 30071857
[TBL] [Abstract][Full Text] [Related]
7. Risk factors associated with secondary enucleation after fractionated stereotactic radiotherapy in uveal melanoma.
van den Bosch T; Vaarwater J; Verdijk R; Muller K; Kiliç E; Paridaens D; de Klein A; Naus N
Acta Ophthalmol; 2015 Sep; 93(6):555-60. PubMed ID: 25879399
[TBL] [Abstract][Full Text] [Related]
8. Every other day stereotactic radiation therapy for the treatment of uveal melanoma decreases toxicity.
Yazici G; Kiratli H; Ozyigit G; Sari SY; Elmali A; Yilmaz MT; Koc I; Deliktas O; Gumeler E; Cengiz M; Zorlu F
Radiother Oncol; 2022 Nov; 176():39-45. PubMed ID: 36184996
[TBL] [Abstract][Full Text] [Related]
9. Systematic Review and Meta-Analysis on the Use of Photon-based Stereotactic Radiosurgery Versus Fractionated Stereotactic Radiotherapy for the Treatment of Uveal Melanoma.
Kosydar S; Robertson JC; Woodfin M; Mayr NA; Sahgal A; Timmerman RD; Lo SS
Am J Clin Oncol; 2021 Jan; 44(1):32-42. PubMed ID: 33208706
[TBL] [Abstract][Full Text] [Related]
10. Transscleral local resection versus iodine brachytherapy for uveal melanomas that are large because of tumour height.
Puusaari I; Damato B; Kivelä T
Graefes Arch Clin Exp Ophthalmol; 2007 Apr; 245(4):522-33. PubMed ID: 17111148
[TBL] [Abstract][Full Text] [Related]
11. Plaque radiotherapy of uveal melanoma with predominant ciliary body involvement.
Gündüz K; Shields CL; Shields JA; Cater J; Freire JE; Brady LW
Arch Ophthalmol; 1999 Feb; 117(2):170-7. PubMed ID: 10037560
[TBL] [Abstract][Full Text] [Related]
12. Posterior uveal melanoma treated with I-125 brachytherapy or primary enucleation.
Krohn J; Monge OR; Skorpen TN; Mørk SJ; Dahl O
Eye (Lond); 2008 Nov; 22(11):1398-403. PubMed ID: 17585309
[TBL] [Abstract][Full Text] [Related]
13. Quality of life: fractionated stereotactic radiotherapy versus enucleation treatment in uveal melanoma patients.
van Beek JGM; Buitendijk GHS; Timman R; Muller K; Luyten GPM; Paridaens D; Naus NC; Kiliç E
Acta Ophthalmol; 2018 Dec; 96(8):841-848. PubMed ID: 30284368
[TBL] [Abstract][Full Text] [Related]
14. Retrospective analysis of secondary enucleation for uveal melanoma after plaque radiotherapy.
Wang H; Zhang R; Wang Y; Chen R; Liu Y; Li Y; Wei W
BMC Ophthalmol; 2022 Apr; 22(1):163. PubMed ID: 35397506
[TBL] [Abstract][Full Text] [Related]
15. Estimates of ocular and visual retention following treatment of extra-large uveal melanomas by proton beam radiotherapy.
Conway RM; Poothullil AM; Daftari IK; Weinberg V; Chung JE; O'Brien JM
Arch Ophthalmol; 2006 Jun; 124(6):838-43. PubMed ID: 16769837
[TBL] [Abstract][Full Text] [Related]
16. Proton beam irradiation of uveal melanoma involving the iris, ciliary body and anterior choroid without surgical localisation (light field).
Oxenreiter MM; Lane AM; Aronow MB; Shih H; Trofimov AV; Kim IK; Gragoudas ES
Br J Ophthalmol; 2022 Apr; 106(4):518-521. PubMed ID: 33355171
[TBL] [Abstract][Full Text] [Related]
17. Intravitreal bevacizumab for neovascular glaucoma in uveal melanoma treated by proton beam therapy.
Mahdjoubi A; Najean M; Lemaitre S; Dureau S; Dendale R; Levy C; Rouic LL; Desjardins L; Cassoux N
Graefes Arch Clin Exp Ophthalmol; 2018 Feb; 256(2):411-420. PubMed ID: 29116399
[TBL] [Abstract][Full Text] [Related]
18. Plaque radiotherapy for large posterior uveal melanomas (> or =8-mm thick) in 354 consecutive patients.
Shields CL; Naseripour M; Cater J; Shields JA; Demirci H; Youseff A; Freire J
Ophthalmology; 2002 Oct; 109(10):1838-49. PubMed ID: 12359604
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of fractionated stereotactic radiotherapy for uveal melanoma.
Muller K; Nowak PJ; de Pan C; Marijnissen JP; Paridaens DA; Levendag P; Luyten GP
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):116-22. PubMed ID: 16111579
[TBL] [Abstract][Full Text] [Related]
20. Ocular complications after iodine brachytherapy for large uveal melanomas.
Puusaari I; Heikkonen J; Kivelä T
Ophthalmology; 2004 Sep; 111(9):1768-77. PubMed ID: 15350335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
